These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures. Verdel BM, Souverein PC, Egberts TC, van Staa TP, Leufkens HG, de Vries F. Bone; 2010 Sep; 47(3):604-9. PubMed ID: 20601295 [Abstract] [Full Text] [Related]
5. Multinational Investigation of Fracture Risk with Antidepressant Use by Class, Drug, and Indication. Tamblyn R, Bates DW, Buckeridge DL, Dixon WG, Girard N, Haas JS, Habib B, Iqbal U, Li J, Sheppard T. J Am Geriatr Soc; 2020 Jul; 68(7):1494-1503. PubMed ID: 32181493 [Abstract] [Full Text] [Related]
7. Antidepressants and the risk of falls among nursing home residents. Thapa PB, Gideon P, Cost TW, Milam AB, Ray WA. N Engl J Med; 1998 Sep 24; 339(13):875-82. PubMed ID: 9744971 [Abstract] [Full Text] [Related]
8. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures. Ziere G, Dieleman JP, van der Cammen TJ, Hofman A, Pols HA, Stricker BH. J Clin Psychopharmacol; 2008 Aug 24; 28(4):411-7. PubMed ID: 18626268 [Abstract] [Full Text] [Related]
9. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors. Baumann P. Clin Pharmacokinet; 1996 Dec 24; 31(6):444-69. PubMed ID: 8968657 [Abstract] [Full Text] [Related]
13. [Comparison of the efficacy of traditional antidepressive agents and the new generation of antidepressives in the treatment of depressive disorders]. Cvjetković-Bosnjak M, Knezević A, Soldatović-Stajić B. Med Pregl; 1999 Dec 24; 52(3-5):108-11. PubMed ID: 10518394 [Abstract] [Full Text] [Related]
14. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Sauer WH, Berlin JA, Kimmel SE. Circulation; 2003 Jul 08; 108(1):32-6. PubMed ID: 12821544 [Abstract] [Full Text] [Related]
15. Antidepressant use and risk of adverse outcomes in people aged 20-64 years: cohort study using a primary care database. Coupland C, Hill T, Morriss R, Moore M, Arthur A, Hippisley-Cox J. BMC Med; 2018 Mar 08; 16(1):36. PubMed ID: 29514662 [Abstract] [Full Text] [Related]
16. Risk of fractures with selective serotonin-reuptake inhibitors or tricyclic antidepressants. Ginzburg R, Rosero E. Ann Pharmacother; 2009 Jan 08; 43(1):98-103. PubMed ID: 19116378 [Abstract] [Full Text] [Related]
17. Retrospective study of selegiline-antidepressant drug interactions and a review of the literature. Ritter JL, Alexander B. Ann Clin Psychiatry; 1997 Mar 08; 9(1):7-13. PubMed ID: 9167831 [Abstract] [Full Text] [Related]
18. In vivo effect of antidepressants on [3H]paroxetine binding to serotonin transporters in rat brain. Nadgir SM, Malviya M. Neurochem Res; 2008 Nov 08; 33(11):2250-6. PubMed ID: 18437564 [Abstract] [Full Text] [Related]
19. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N. Lancet; 1998 May 02; 351(9112):1303-7. PubMed ID: 9643791 [Abstract] [Full Text] [Related]
20. Inhibition and possible induction of rat CYP2D after short- and long-term treatment with antidepressants. Daniel WA, Haduch A, Wójcikowski J. J Pharm Pharmacol; 2002 Nov 02; 54(11):1545-52. PubMed ID: 12495558 [Abstract] [Full Text] [Related] Page: [Next] [New Search]